Robert Hershberg
CIK: 0001274139
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Oct 6, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
Exercise(M)Direct25K shares at avg. $2.22$56K - Oct 6, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
Sale(S)Direct25K shares at avg. $5.00$125K - Sep 11, 2026ATAI
AtaiBeckley Inc.
Disposition(D)DirectStock Option
103K shares- - Sep 11, 2026ATAI
AtaiBeckley Inc.
Disposition(D)DirectStock Option
62.4K shares- - Sep 11, 2026ATAI
AtaiBeckley Inc.
Disposition(D)DirectStock Option
404.9K shares- - Sep 11, 2026ATAI
AtaiBeckley Inc.
Disposition(D)DirectStock Option
122K shares- - Sep 11, 2026ATAI
AtaiBeckley Inc.
Disposition(D)DirectStock Option
48.9K shares- - Aug 18, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct15K shares at avg. $24.39$366K - Aug 18, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct15.7K shares at avg. $24.41$382K - Aug 18, 2026ADPT
Adaptive Biotechnologies Corp
Exercise(M)Direct15K shares at avg. $6.32$95K - Jul 7, 2026ATAI
AtaiBeckley Inc.
Exercise(M)Direct51.1K shares at avg. $1.35$69K - Jul 7, 2026ATAI
AtaiBeckley Inc.
Exercise(M)Direct48.9K shares at avg. $1.35$66K - Jul 7, 2026ATAI
AtaiBeckley Inc.
Sale(S)Direct100K shares at avg. $4.96$496K - Jun 17, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
Award(A)Direct88.4K shares- - Jun 4, 2026ATAI
AtaiBeckley Inc.
Award(A)DirectStock Option
122K shares- - Mar 4, 2026ADPT
Adaptive Biotechnologies Corp
Award(A)Direct15.6K shares- - Dec 10, 2025ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct23K shares at avg. $16.00$367K - Nov 5, 2025ATAI
Atai Beckley N.V.
Award(A)DirectStock Option
103K shares- - Nov 5, 2025ATAI
Atai Beckley N.V.
Award(A)DirectStock Option
456K shares- - Nov 5, 2025ATAI
Atai Beckley N.V.
Award(A)DirectStock Option
97.7K shares- - Nov 5, 2025ATAI
Atai Beckley N.V.
Award(A)DirectStock Option
62.4K shares- - Sep 17, 2025HLVX
HilleVax, Inc.
Tender Offer(U)Direct1.1M shares- - Jun 18, 2025RXRX
RECURSION PHARMACEUTICALS, INC.
Award(A)Direct22K shares- - Mar 12, 2025ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct53K shares at avg. $7.59$402K - Mar 4, 2025ADPT
Adaptive Biotechnologies Corp
Award(A)Direct15.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 |  RXRX RECURSION PHARMACEUTICALS, INC. | Exercise(M) | 25,000 | $2.22 | $55,500 | Direct |
| Oct 6, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale(S) | 25,000 | $5.00 | $125,000 | Direct |
| Sep 11, 2026 |  ATAI AtaiBeckley Inc. | Disposition(D) Stock Option | 103,000 | - | - | Direct |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | Disposition(D) Stock Option | 62,394 | - | - | Direct |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | Disposition(D) Stock Option | 404,869 | - | - | Direct |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | Disposition(D) Stock Option | 121,968 | - | - | Direct |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | Disposition(D) Stock Option | 48,858 | - | - | Direct |
| Aug 18, 2026 |  ADPT Adaptive Biotechnologies Corp | Sale(S) | 15,000 | $24.39 | $365,850 | Direct |
| Aug 18, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 15,664 | $24.41 | $382,358 | Direct |
| Aug 18, 2026 | ADPT Adaptive Biotechnologies Corp | Exercise(M) | 15,000 | $6.32 | $94,800 | Direct |
| Jul 7, 2026 | ATAI AtaiBeckley Inc. | Exercise(M) | 51,142 | $1.35 | $69,042 | Direct |
| Jul 7, 2026 | ATAI AtaiBeckley Inc. | Exercise(M) | 48,858 | $1.35 | $65,958 | Direct |
| Jul 7, 2026 | ATAI AtaiBeckley Inc. | Sale(S) | 100,000 | $4.96 | $496,000 | Direct |
| Jun 17, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award(A) | 88,424 | - | $0 | Direct |
| Jun 4, 2026 | ATAI AtaiBeckley Inc. | Award(A) Stock Option | 121,968 | - | - | Direct |
| Mar 4, 2026 | ADPT Adaptive Biotechnologies Corp | Award(A) | 15,625 | - | $0 | Direct |
| Dec 10, 2025 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 22,968 | $16.00 | $367,488 | Direct |
| Nov 5, 2025 | ATAI Atai Beckley N.V. | Award(A) Stock Option | 103,000 | - | - | Direct |
| Nov 5, 2025 | ATAI Atai Beckley N.V. | Award(A) Stock Option | 456,011 | - | - | Direct |
| Nov 5, 2025 | ATAI Atai Beckley N.V. | Award(A) Stock Option | 97,716 | - | - | Direct |
| Nov 5, 2025 | ATAI Atai Beckley N.V. | Award(A) Stock Option | 62,394 | - | - | Direct |
| Sep 17, 2025 |  HLVX HilleVax, Inc. | Tender Offer(U) | 1,101,498 | - | - | Direct |
| Jun 18, 2025 | RXRX RECURSION PHARMACEUTICALS, INC. | Award(A) | 22,016 | - | - | Direct |
| Mar 12, 2025 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 53,000 | $7.59 | $402,270 | Direct |
| Mar 4, 2025 | ADPT Adaptive Biotechnologies Corp | Award(A) | 15,394 | - | - | Direct |
1-25 of 27 transactions
About HERSHBERG ROBERT
HERSHBERG ROBERT (SEC CIK 0001274139) files insider reports with the SEC as Director of DANAHER CORP /DE/ (DHR), Director of RECURSION PHARMACEUTICALS, INC. (RXRX) and Director of AtaiBeckley Inc. (ATAI). Signal8 also holds filings tied to 3 other companies.
Signal8 holds 16 ownership filings by HERSHBERG ROBERT (2 Form 3, 14 Form 4), filed between Feb 12, 2025 and Oct 16, 2026. Those filings report 27 transactions, from Feb 4, 2025 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HERSHBERG ROBERT's filings is in SALT LAKE CITY, UT.
Recent filings by HERSHBERG ROBERT
- Oct 6, 2026: Option exercise of RXRX shares (Form 4, code M).
- Oct 6, 2026: Open-market sale of RXRX shares (Form 4, code S).
- Sep 11, 2026: Disposition to issuer transactions of ATAI derivative securities (5 lines, Form 4, code D).
- Aug 18, 2026: Open-market sales of ADPT shares (2 lines, Form 4, code S).
- Aug 18, 2026: Option exercise of ADPT shares (Form 4, code M).
Other insiders filing for DANAHER CORP /DE/ (DHR)
- Zerhouni Elias A., Director
- Dewan Feroz, Director
- FILLER LINDA, Director
- List Teri, Director
- Stevens Raymond C, Director
- Sanders A Shane, Director